This Article Full Text (PDF) All Versions of this Article: 1933719109340926v1 16/11/1052    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Anderson, L. Articles by Norman, J. E. PubMed PubMed Citation Articles by Anderson, L. Articles by Martin, W. Articles by Higgins, C. Articles by Nelson, S. M. Articles by Norman, J. E. Social Bookmarking                         What's this?

The Effect of Progesterone on Myometrial Contractility, Potassium Channels, and Tocolytic Efficacy

Reproductive and Maternal Medicine, Institute of Biomedical and Life Sciences University of Glasgow, Scotland, UK, laurieanderson{at}doctors.org.uk

William Martin, PhD

Integrative and Systems Biology, Institute of Biomedical and Life Sciences University of Glasgow, Scotland, UK

Claire Higgins, BSc, MBChB

Reproductive and Maternal Medicine, Institute of Biomedical and Life Sciences University of Glasgow, Scotland, UK

Scott M. Nelson, PhD, MRCOG

Reproductive and Maternal Medicine, Institute of Biomedical and Life Sciences University of Glasgow, Scotland, UK

Jane E. Norman, MD, MRCOG

Centre for Reproductive Biology, University of Edinburgh, Scotland, UK

Objectives: Recent clinical trials have demonstrated a beneficial effect of supplementation with progesterone to prevent preterm labor. We aimed to determine the effects of progesterone treatment in vitro and in vivo and 17-hydroxyprogesterone caproate (17OHPC) in vitro on myometrial contractions. Methods: Myometrial strips were taken from women undergoing cesarean delivery at term. We also obtained myometrial biopsies from women participating in a clinical trial of progesterone to prevent preterm labor in twins (STOPPIT). After establishment of spontaneous contractions, strips were exposed to progesterone or 17OHPC. Separate strips were exposed to oxytocin and tocolytics alone and in combination with progesterone. Potassium channel blockers were added in conjunction with progesterone. STOPPIT samples were used to compare the effects of in vivo progesterone and placebo. We measured amplitude, frequency and activity integral of contractions. Results: Maximum inhibition of contraction amplitude was 93 ± 2% and 67 ± 14% for progesterone at 30 µM and vehicle (70% ethanol), respectively, P < 0.05. 17OHPC did not exert an inhibitory effect. Water soluble progesterone exerted a maximal inhibitory effect on amplitude of contractions of 82 ± 10% at 100 µM, P < 0.05. The inhibitory effect of progesterone was unaffected by potassium channel blockers. There was no difference between in vivo placebo and progesterone-treated groups in either amplitude or frequency of contractions, nor was there any difference in the response to oxytocin or the tocolytic drugs. Conclusions: Progesterone exerts rapid inhibition of the amplitude of myometrial contractions in vitro but 17OHPC does not. The action of progesterone does not appear to operate via potassium channels nor does it enhance the activity of certain tocolytic drugs.

Key Words: Myometrial • contractility • progesterone • potassium channels • tocolytics.

This version was published on November 1, 2009

Reproductive Sciences, Vol. 16, No. 11, 1052-1061 (2009)
DOI: 10.1177/1933719109340926


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?